Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
U.S. authorities are assessing whether certain cryptocurrency platforms have been used to help Iranian state-linked actors and others evade sanctions, as blockchain firms record a surge in crypto flows connected to Iran. Estimates from multiple analytics firms point to billions of dollars in on-chain activity in recent years, with disagreement over…
Richmond Federal Reserve President Tom Barkin said the rate cuts enacted since fall 2024 have provided insurance for the labor market as the Fed works to finish the ‘last mile’ of returning inflation to its 2% goal. Barkin noted that unemployment remains low by historical measures and inflation is about one percentage point above target but is expe…
Federal Reserve Governor Stephen Miran told Fox Business Network he expects more than a percentage point of interest rate reductions this year, arguing current policy is too restrictive even though headline inflation remains above the 2% target. Miran, whose term technically ended at the close of January but who remains in office until a successor …
Guggenheim increased its price target for McDonald’s to $325 from $310 while leaving its rating at Neutral, raising 2026 EPS estimates and expanding the valuation multiple. The firm also revised same-store sales expectations for late 2025 and reported on new product tests. Other broker notes ahead of McDonald’s fourth-quarter results show a range o…
Scotiabank reduced its price target for Oracle to $220 from $260 while retaining a Sector Outperform rating, citing the company's $45-50 billion capital plan and remaining medium-term financing questions tied to the Oracle Cloud Infrastructure buildout. The bank trimmed Oracle's fiscal 2026 and 2027 EPS forecasts and flagged execution on major data…
Apple's newest window of upside is less about heavy new factories and more about software-led AI features that accelerate iPhone replacement and lift services monetization. The company prints massive free cash flow and runs a disciplined capital plan; combine that with early signs of a 23% iPhone sales surge and constructive technicals and you have…
SpaceX has acquired xAI, bringing the Grok chatbot maker together with the rocket-and-satellite company and creating a combined platform that ties artificial intelligence and space operations under a single corporate umbrella. The transaction assigns valuations of $1 trillion to SpaceX and $250 billion to xAI, and takes place as SpaceX prepares for…
GLJ Research cut its rating on Daqo New Energy (NYSE: DQ) from Buy to Sell and assigned a new price target of $18.13, reflecting a material downside from recent levels. The downgrade cites uncertainty in China’s polysilicon supply-and-demand balance and regulatory execution, while company-level metrics show a projected revenue decline and deeply ne…
Futures tied to Canada’s main stock index moved higher as gold prices stabilized after steep losses and traders prepared for a large slate of corporate results. Strength in consumer sectors supported the TSX rebound, while the energy group remained pressured by softer oil following signs of easing U.S.-Iran tensions. U.S. futures also ticked up ami…
Arbutus is a small-cap clinical-stage biotech where two near-term vectors - LNP-related litigation and follow-up imdusiran efficacy readouts - can produce outsized moves. Market capitalization sits near $844M while recent clinical data showed meaningful reductions in HBsAg. High short interest and above-average volume amplify both upside and downsi…
Stephens Research’s 2026 Best Ideas list highlights a selection of consumer-focused companies the firm expects to outperform peers next year. The brokerage emphasizes that durable brands, the ability to raise prices and idiosyncratic operational improvements - rather than broad macro trends - underpin the call. Top picks span specialty retail, cons…
Saudi Arabia's stock market closed modestly higher on Tuesday, with the Tadawul All Share rising 0.07%. Strength in the Cement, Industrial Investment and Media & Publishing sectors underpinned the advance, while market breadth remained mixed as more issues declined than advanced. Several individual stocks posted double-digit moves in percentage ter…
Capri Holdings raised its fiscal 2026 revenue guidance, citing continued demand for apparel and handbags across its Jimmy Choo and Michael Kors brands. The company reported a 4% decline in quarterly revenue to $1.03 billion but exceeded analysts' revenue and EPS estimates, and said Jimmy Choo delivered a sales gain while Michael Kors sales remained…
JPMorgan repeated its Overweight rating and $138.00 price target on The Walt Disney Company after the firm's fiscal first-quarter results, even as investors reacted to second-quarter commentary and a perceived shift in reporting detail. The bank sees value at under 16 times forward earnings while other firms also offered supportive ratings amid mix…
Acadia Pharmaceuticals received a negative trend vote from the European Medicines Agency's CHMP on its Marketing Authorization Application for trofinetide, marketed as Daybue in the U.S. The company says it will request a re-examination when the CHMP opinion is formally adopted in February. Despite the regulatory headwind, several analysts have rei…
Canaccord Genuity raised its price target on WAVE Life Sciences to $43 from $40 and kept a Buy rating after the company regained full global rights to its investigational RNA editing candidate WVE-006 from GSK. The move prompted analysts to increase revenue assumptions and prompted renewed focus on an accelerated regulatory path, while market data …
Canaccord Genuity reduced its price target for Roblox Corp. to $140 from $160 while retaining a Buy rating, pointing to potential margin strain as the platform increases infrastructure spending to support higher engagement and product diversification. The firm projects substantial year-over-year growth in daily active users, gross bookings and net …
JPMorgan trimmed its 12-month price objective for ESAB to $130 from $138 but retained an Overweight rating. The downgrade reflects the expected short-term earnings hit from ESAB’s pending $1.45 billion purchase of Eddyfi and concerns that leverage will stay at or above roughly 3x until early 2027. The firm questioned the deal multiple and described…
S&P Global Ratings warns that African governments face mounting external repayment pressures in 2026, with government external debt repayments likely to exceed $90 billion this year. The agency highlights that repayments are now more than three times larger than in 2012, and that a handful of countries - led by Egypt with $27 billion due in princip…
WarrenAI's recent assessment ranks Microsoft Corporation and NVIDIA Corporation as the two most compelling investment opportunities among the Magnificent Seven. The analysis highlights analyst price targets, projected earnings and revenue growth, and valuation metrics to support the pair's positions, emphasizing AI and cloud momentum for Microsoft …
Salesforce is trading near multi-month lows despite healthy margins, strong free cash flow, and a clear path to AI-led product monetization. Use a defined-entry trade to capture a rebound as Agentforce 360 and broader generative AI adoption begin to show through in revenue and ARR acceleration.
Minutes from the central bank's January 28 meeting show the board left the Selic rate at 15% and said it will determine the magnitude and duration of any easing cycle based on evolving economic data. Policymakers stressed maintaining restrictive policy until disinflation is consolidated and inflation expectations align with targets, while noting th…
Rosenblatt has reaffirmed a Buy rating and a $550 price objective for Fabrinet following the company's fiscal 2026 second-quarter results and guidance for the third quarter. Fabrinet reported $1.13 billion in Q2 revenue and non-GAAP EPS of $3.36, and provided Q3 revenue and EPS guidance that implies continued growth. Strength in the Telecom segment…
Raymond James' technical assessment of Newmont Corporation (NEM) identifies negative momentum, weakening relative strength versus the S&P 500, and early selling-pressure volume patterns that may herald a short-term corrective phase. The firm outlines potential support tests at the 50-day moving average near $103.65 and at $97.99, with a weekly brea…
H.C. Wainwright has reiterated a Buy rating on Wave Life Sciences (WVE) and set a $30.00 price target after the company recovered global rights to its RNA editing candidate WVE-006 from GlaxoSmithKline. The research firm points to a clearer regulatory path for alpha-1 antitrypsin deficiency (AATD) accelerated approval and notes additional analyst s…
